|
|
Vaccine Detail
|
Electrofusion DC vaccine |
| Vaccine Information |
- Vaccine Name: Electrofusion DC vaccine
- Target Pathogen: Cancer
- Target Disease: Cancer
- Type: whole cell cancer vaccine
- Status: Clinical trial
- Host Species for Licensed Use: None
- Immunization Route: subcutaneous injection
- Description: PEG fusions are generated from allogeneic dendritic cells and autologous tumor-derived cells with GM-CSF and Il-4. The vaccine is irradiated, frozen, and thawed before being administered to patients with AJCC Stage IV Renal Cell Carcinoma. The vaccine could have and effect on the immune system and cancer. (NCT00625755)
|
| Host Response |
|
|
| References |
|
|
|
